| ||||||||||||||
|
|
|||||||||||||
Departments of Anaesthetics and Intensive Care and Biological Sciences, Imperial College London
Address correspondence and reprint requests to Mervyn Maze, MB, ChB, FRCP, FRC, Sir Ivan Magill Professor of Anesthetics, Imperial College, Chelsea and Westminster Hospital, 369 Fulham Road, London SW10 9NH. Address e-mail to m.maze{at}ic.ac.uk.
Dexmedetomidine (Dex), an
2-adrenoceptor agonist, is an effective analgesic and sedative drug in adults; however, little information is available about its efficacy in pediatric populations. Some anesthetics exhibit an age-dependent analgesic effect, e.g., nitrous oxide, being relatively ineffective in newborn rats. We investigated the analgesic and hypnotic efficacy of Dex using 6 cohorts of Fischer rats aged 7, 15, 19, 23, and 29 days and adults exposed to either Dex (10 or 50 µg/kg) or saline subcutaneously. Formalin plantar testing was used to mimic inflammatory pain, and its effect was assessed using immunohistochemical (c-Fos staining) and behavioral methods. The hypnotic action of Dex was assessed by loss of righting reflex. Formalin administration produced a typical nociceptive response in each age group; these nociceptive responses were significantly attenuated by Dex 50 µg/kg at all ages (P < 0.05), whereas Dex 10 µg/kg had little effect. Neonatal rats showed the greatest hypnotic sensitivity to Dex (P < 0.05).
This article has been cited by other articles:
![]() |
R. D. Sanders, D. Ma, P. Brooks, and M. Maze Balancing paediatric anaesthesia: preclinical insights into analgesia, hypnosis, neuroprotection, and neurotoxicity Br. J. Anaesth., November 1, 2008; 101(5): 597 - 609. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. M. Walker Pain in children: recent advances and ongoing challenges Br. J. Anaesth., July 1, 2008; 101(1): 101 - 110. [Abstract] [Full Text] [PDF] |
||||
|